$ブラック ダイヤモンド セラピューティクス(BDTX.US)$ NEWS Black Diamond Therapeutics, Inc. presents real-world data at AACR Annual Meeting showcasing the potential of BDTX-1535, the most advanced fourth-generation oral TKI, to target a wide range of classical, non-classical, and C797S resistance EGFR mutations in NSCLC patients. The compound demonstrates potent inhibition of over 50 clinically relevant non-classical EGFR mutations and the C797S resistance mutation, offering a promising treatment option for EGF...
Alvinnnnnnngeniusスレ主 :
I’m not saying this is a buy but this is a very good examples how a stock can go up 100-300% without volume , some volume are pump by some influence and some pumpers to increase volume to actually make them easier to short a stock to make profit
ブラック ダイヤモンド セラピューティクスに関するコメント
NEWS
Black Diamond Therapeutics, Inc. presents real-world data at AACR Annual Meeting showcasing the potential of BDTX-1535, the most advanced fourth-generation oral TKI, to target a wide range of classical, non-classical, and C797S resistance EGFR mutations in NSCLC patients. The compound demonstrates potent inhibition of over 50 clinically relevant non-classical EGFR mutations and the C797S resistance mutation, offering a promising treatment option for EGF...
$ブラック ダイヤモンド セラピューティクス(BDTX.US)$
$NWTN B(NWTN.US)$
$ライブワイヤー グループ(LVWR.US)$
まだコメントはありません